---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275813845.md"
description: "Bio-Rad Laboratories shares are trading lower after the company reported mixed Q4 financial results and issued FY26 sales guidance below estimates."
datetime: "2026-02-12T21:50:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275813845.md)
  - [en](https://longbridge.com/en/news/275813845.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275813845.md)
generator: "portal-rs"
---

# 

Bio-Rad Laboratories shares are trading lower after the company reported mixed Q4 financial results and issued FY26 sales guidance below estimates.

### Related Stocks

- [BIO.US](https://longbridge.com/en/quote/BIO.US.md)

## Related News & Research

- [First Trust Advisors LP Has $424,000 Position in Bio-Rad Laboratories, Inc. $BIO](https://longbridge.com/en/news/295758912.md)
- [Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth](https://longbridge.com/en/news/294867295.md)
- [Top Johnson & Johnson Executive Makes Major Stock Move](https://longbridge.com/en/news/298086145.md)
- [Pegasystems (PEGA), Why Is It Back In The Spotlight?](https://longbridge.com/en/news/297761657.md)
- [Audacity 4 is a complete revamp of the ‘world’s most popular’ audio editor](https://longbridge.com/en/news/298078082.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**